I don't really follow the stock, so didn't listen to the call. The liver elevations on closer examination are only a modest signal, but the issue is the FDA has been bitten on prior liver issues with antibiotics so they might be a bit gun shy.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.